New patent for Boehringer Ingelheim drug GLYXAMBI

Annual Drug Patent Expirations for GLYXAMBI Glyxambi is a drug marketed by Boehringer Ingelheim and is included in one NDA. It is available from one supplier. There are thirteen patents…
The post New patent for Boehringer Ingelheim drug GLYXAMBI appear…


Which pharmaceutical drugs have the most drug patents in Chile?

This chart shows the drugs with the most patents in Chile. Patents must be filed in each country (or, in some cases regional patent office) where patent protection is desired.…
The post Which pharmaceutical drugs have the most drug patents in Chile? ap…


Biotechblog